BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10403092)

  • 1. Beta-blocker therapy in heart failure: pathophysiology and clinical results.
    Carson PE
    Curr Probl Cardiol; 1999 Jul; 24(7):421-60. PubMed ID: 10403092
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 4. In heart failure, all beta-blockers are not necessarily equal.
    Tang WH; Militello M; Francis GS
    Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New milestones in the therapy of chronic heart failure with beta blockers].
    Garlichs C; Daniel WG
    Z Kardiol; 2000 Mar; 89(3):236-8. PubMed ID: 10798280
    [No Abstract]   [Full Text] [Related]  

  • 6. Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary).
    Rajput FS; Gnanasekeram H; Satwani S; Davenport JD; Gracely EJ; Gopalan R; Narula J
    Am J Cardiol; 2003 Jul; 92(2):218-21. PubMed ID: 12860230
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-blockers for chronic heart failure: surviving longer but feeling better?
    Bolger AP; Al-Nasser F
    Int J Cardiol; 2003 Nov; 92(1):1-8. PubMed ID: 14602210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
    J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
    MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major beta blocker mortality trials in chronic heart failure: a critical review.
    McMurray JJ
    Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta blockers and congestive heart failure.
    Movahed A
    Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
    [No Abstract]   [Full Text] [Related]  

  • 13. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta blockers for therapy of chronic heart failure].
    Murakami T
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
    Whorlow SL; Krum H
    Am J Cardiol; 2000 Oct; 86(8):886-9. PubMed ID: 11024409
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
    Di Lenarda A; Sabbadini G; Sinagra G
    Cardiovasc Drugs Ther; 2004 Mar; 18(2):91-3. PubMed ID: 15293370
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
    Clin Res Cardiol; 2017 Sep; 106(9):711-721. PubMed ID: 28434020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
    Lee S; Spencer A
    J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L
    Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.